GNC (NYSE:GNC) posted its quarterly earnings data on Friday. The specialty retailer reported $0.02 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.04 by ($0.02), Briefing.com reports. GNC had a negative net margin of 7.06% and a negative return on equity of 57.85%. The business had revenue of $580.00 million for the quarter, compared to analysts’ expectations of $580.45 million. During the same quarter in the previous year, the firm earned $0.32 EPS. GNC’s revenue was down 5.4% compared to the same quarter last year.
NYSE GNC traded down $0.07 on Friday, reaching $4.22. 2,635,244 shares of the stock traded hands, compared to its average volume of 2,168,274. The firm has a market cap of $365.76 million, a PE ratio of 3.13 and a beta of 0.54. GNC has a 12 month low of $2.71 and a 12 month high of $6.93.
Hedge funds and other institutional investors have recently modified their holdings of the business. Spark Investment Management LLC bought a new stake in GNC during the 2nd quarter valued at $381,000. Price Capital Management Inc. bought a new stake in GNC during the 2nd quarter valued at $607,000. Bank of New York Mellon Corp raised its position in GNC by 7.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 345,561 shares of the specialty retailer’s stock valued at $1,217,000 after purchasing an additional 24,656 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in GNC by 24.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 935,890 shares of the specialty retailer’s stock valued at $3,295,000 after purchasing an additional 186,073 shares in the last quarter. Finally, Gabelli Funds LLC raised its position in GNC by 28.6% during the 2nd quarter. Gabelli Funds LLC now owns 225,000 shares of the specialty retailer’s stock valued at $792,000 after purchasing an additional 50,000 shares in the last quarter. 47.33% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts recently issued reports on the company. Barclays restated a “sell” rating and set a $3.00 price objective on shares of GNC in a report on Friday, July 27th. Buckingham Research assumed coverage on GNC in a report on Monday, October 29th. They set a “buy” rating and a $6.00 price objective for the company. Finally, Zacks Investment Research cut GNC from a “hold” rating to a “sell” rating in a report on Tuesday, July 31st. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. GNC presently has a consensus rating of “Hold” and an average price target of $4.50.
ILLEGAL ACTIVITY NOTICE: This piece was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/11/10/gnc-gnc-announces-earnings-results-misses-estimates-by-0-02-eps.html.
GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. It operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink, and other general merchandise.
Recommended Story: How dollar cost averaging works
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.